Home Biosimilar Antibodies Protein Tyrosine Kinase IGF-1R antibody Lonigutamab (Anti-IGF1R / CD221) For research use only.
Not for use in humans.

Lonigutamab (Anti-IGF1R / CD221)

Synonyms:

Lonigutamab (hz208F2-4) is a humanized monoclonal antibody against the insulin-like growth factor-1 receptor (IGF-1R) with the potential to treat thyroid eye disease (TED). MW: 146.26 KD.

Lonigutamab (Anti-IGF1R / CD221)

Purity & Quality Control

≥99

Choose Selective IGF-1R Inhibitors

Biological Activity

Description Lonigutamab (hz208F2-4) is a humanized monoclonal antibody against the insulin-like growth factor-1 receptor (IGF-1R) with the potential to treat thyroid eye disease (TED). MW: 146.26 KD.

Product Details

CAS No. 2362015-67-4
Molecular Weight 146.26
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Lonigutamab (Anti-IGF1R / CD221) | Lonigutamab (Anti-IGF1R / CD221) supplier | purchase Lonigutamab (Anti-IGF1R / CD221) | Lonigutamab (Anti-IGF1R / CD221) cost | Lonigutamab (Anti-IGF1R / CD221) manufacturer | order Lonigutamab (Anti-IGF1R / CD221) | Lonigutamab (Anti-IGF1R / CD221) distributor